Reply: Weight-Loss Effect on FVC in Nintedanib Idiopathic Pulmonary Fibrosis Trials?

Am J Respir Crit Care Med. 2015 Oct 15;192(8):1020-1. doi: 10.1164/rccm.201507-1354LE.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Enzyme Inhibitors / administration & dosage*
  • Female
  • Humans
  • Idiopathic Pulmonary Fibrosis / drug therapy*
  • Indoles / administration & dosage*
  • Male
  • Protein Kinase Inhibitors / administration & dosage*

Substances

  • Enzyme Inhibitors
  • Indoles
  • Protein Kinase Inhibitors